Search results for "Fever"

showing 10 items of 247 documents

Rotavirus gastroenteritis in Italian children: can severity of symptoms be related to the infecting virus?

2001

The aim of our study was to determine whether the severity of rotavirus gastroenteritis may be related to the different characteristics of infecting viral strains. The severity of clinical symptoms in 401 children with acute rotavirus gastroenteritis was assessed using a scoring system for frequency and duration of vomiting, diarrhea, and fever, as well as the patients' requirements for intravenous rehydration. Rotavirus strains were characterized by determining the electropherotype of their double-stranded RNA, the G type and subgroup by a panel of monoclonal antibodies, and the P type by reverse transcription-polymerase chain reaction. Strains with a short electropherotype, G2P[4] type, a…

Microbiology (medical)DiarrheaMaleRotavirusmedicine.medical_specialtyTime FactorsFeverVomitingReoviridaemedicine.disease_causeSeverity of Illness IndexVirusRotavirus InfectionsChild Rotavirusrotavirus; gastroenteritisRotavirusEpidemiologymedicineHumansTypingChildbiologybusiness.industryInfant NewbornInfantbiology.organism_classificationVirologyGastroenteritisDiarrheaInfectious DiseasesItalyChild PreschoolImmunologyVomitingFemaleViral diseasemedicine.symptombusinessClinical infectious diseases : an official publication of the Infectious Diseases Society of America
researchProduct

Q fever in Europe: current aspects of aetiology, epidemiology, human infection, diagnosis and therapy.

1987

Il s'agit d'une zoonose. Elle est en general asymptomatique bien que des decouvertes nouvelles aussi bien chez l'homme que chez l'animal mettent en evidence des syndromes cliniques associes en particulier des maladies chroniques graves

Microbiology (medical)Gynecologymedicine.medical_specialtyPathologybusiness.industryQ feverGeneral MedicineInfection diagnosismedicine.diseaseEuropeInfectious DiseasesCoxiellaGeneral practiceEpidemiologyAcute DiseaseBacterial VaccinesChronic DiseasemedicineEtiologyAnimalsHumansbusinessQ FeverInfection
researchProduct

Infección por Coxiella burnetii (fiebre Q)

2010

In spite of being described over 60 years, Q fever is still a little known disease. The exact prevalence is also unknown, but probably the number of cases of Q fever is underestimated. There is much variation in the clinical presentation, including severe forms with a poor prognosis. Acute cases often present as an asymptomatic infection, flu-like syndrome, pneumonia or hepatitis. Presumably, host factors play an important role in the development of chronic disease, which may present as endocarditis with negative blood culture. The diagnosis of Q fever should be considered in cases of fever of unknown origin, especially if the subject has been in contact with mammals suspicious to be infect…

Microbiology (medical)Hepatitisbiologybusiness.industryQ feverCoxiella burnetiibiology.organism_classificationmedicine.diseaseAsymptomaticImmunologymedicineEndocarditismedicine.symptomSeroconversionFever of unknown originbusinessPneumonia (non-human)Enfermedades Infecciosas y Microbiología Clínica
researchProduct

Israeli Spotted FeverRickettsiain SicilianRhipicephalus sanguineusTicks

2003

To the Editor: Mediterranean spotted fever (MSF) is endemic in Italy, where it is a reportable disease. From 1992 to 1998, the Italian Ministry of Health was notified of approximately 8,500 cases of human rickettsioses presumed to be MSF. MSF occurs more commonly in some central (Lazio) and southern (Sardinia, Sicily, and Calabria) regions (1,2); in 1998, an average of 8.8 cases occurred for every 100,000 persons in Sicily, compared with the national average of 1.6 cases per 100,000 persons. Rickettsia conorii has been thought to be the only pathogenic Rickettsia of the spotted fever group in Sicily (3,4) or the western Mediterranean area. Recently, three different spotted fever group ricke…

Microbiology (medical)Ixodes ricinusEpidemiologyRhipicephalus sanguineusMolecular Sequence Datalcsh:MedicineTicklcsh:Infectious and parasitic diseasesSerologyTicksAnimalslcsh:RC109-216RickettsiaLetters to the Editorbiologylcsh:RRickettsia Infectionsbacterial infections and mycosesbiology.organism_classificationVirologylanguage.human_languageSpotted feverInfectious DiseasesRickettsiaItalylanguageArachnid VectorsRickettsia conoriiSicilianBacterial Outer Membrane ProteinsEmerging Infectious Diseases
researchProduct

Rickettsia conorii Indian Tick Typhus Strain and R. slovaca in Humans, Sicily

2012

Letter to the Editor.-- et al.

Microbiology (medical)LetterSettore MED/17 - Malattie Infettivevector-borne infectionslcsh:MedicineBacteremiaBiologyTickBoutonneuse FeverMicrobiologylcsh:Infectious and parasitic diseasesBacterial proteinBacterial ProteinsSequence Homology Nucleic AcidmedicineHumanslcsh:RC109-216Letters to the EditorSicilyCiencias VeterinariasStrain (biology)RICKETTSIOSIS SICILY TICKlcsh:RMediterranean spotted feverMediterranean spotted fever (Boutonneuse fever)zoonosisIndian tick typhus strainmedicine.diseasebiology.organism_classificationVirologyrickettsiatickRickettsia slovacaBoutonneuse feverRickettsia conoriiInfectious DiseasesCIENCIAS AGRÍCOLASRickettsia slovacaepidemiology//purl.org/becyt/ford/4.3 [https]Rickettsia conorii//purl.org/becyt/ford/4 [https]TyphusMultilocus Sequence TypingEmerging Infectious Diseases
researchProduct

Recent Advances on the Innate Immune Response to Coxiella burnetii.

2021

Coxiella burnetii is an obligate intracellular Gram-negative bacterium and the causative agent of a worldwide zoonosis known as Q fever. The pathogen invades monocytes and macrophages, replicating within acidic phagolysosomes and evading host defenses through different immune evasion strategies that are mainly associated with the structure of its lipopolysaccharide. The main transmission routes are aerosols and ingestion of fomites from infected animals. The innate immune system provides the first host defense against the microorganism, and it is crucial to direct the infection towards a self-limiting respiratory disease or the chronic form. This review reports the advances in understanding…

Microbiology (medical)LipopolysaccharidesImmunologyexperimental modelcytokine—immunological termsQ feverimmunotherapeuticReviewMicrobiologyMicrobiologyImmune systemCellular and Infection MicrobiologyToll-like receptorinflammasomeautophagiamedicineAnimalsHumansPathogeninnate immunityInnate immune systemObligatebiologyTransmission (medicine)MacrophagesInflammasomeCoxiella burnetiibiology.organism_classificationmedicine.diseasebacterial infections and mycosesImmunity InnateQR1-502Toll-like receptorsimmunotherapeuticsInfectious DiseasesCoxiella burnetiibacteriaQ Fevercytokine—immunological termmedicine.drug
researchProduct

Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.

2006

Combination vaccines against common childhood diseases are widely used, provide an improved coverage, are more convenient and are more cost-effective than multiple injections. We conducted a study to evaluate the safety and immunogenicity of a combined measles-mumps-rubella-varicella (MMRV) candidate vaccine in comparison with the separate administration of licensed measles-mumps-rubella (MMR; Priorix) and varicella (V; Varilrix) vaccines.Healthy children 12-18 months of age received 2 doses of MMRV vaccine (3 lots) 6-8 weeks apart (MMRV group) or 1 dose of MMR vaccine administered concomitantly with 1 dose of varicella vaccine, followed by a second dose of MMR at 6-8 weeks later (MMR+V gro…

Microbiology (medical)MaleHerpesvirus 3 HumanFeverPainHyperemiamedicine.vaccineAntibodies ViralRubellaMeaslesCombination vaccinesChickenpox VaccinemedicineHumansVaccines CombinedMeasles mumps rubella varicellaMMRV vaccinebusiness.industryImmunogenicityvirus diseasesInfantmedicine.diseaseInfectious DiseasesMumps virusMeasles virusImmunoglobulin GPediatrics Perinatology and Child HealthImmunologyFemaleViral diseasebusinessMeasles-Mumps-Rubella VaccineThe Pediatric infectious disease journal
researchProduct

Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial

2001

Fifty-one children with Mediterranean spotted fever (MSF) were randomized to receive either clarithromycin, 15 mg/kg/ day orally in 2 divided doses, or chloramphenicol, 50 mg/ kg/day orally in 4 divided doses, for 7 days. Mean time to defervescence was 36.7 h in the clarithromycin group and 47.1 h in the chloramphenicol group (P = .047). Clarithromycin could be an acceptable therapeutic alternative to chloramphenicol and to tetracyclines for children aged <8 years with MSF.

Microbiology (medical)Malemedicine.medical_specialtyBoutonneuse FeverGastroenterologylaw.inventionRandomized controlled trialOral administrationlawClarithromycinInternal medicineClarithromycinmedicineHumansChildAntibacterial agentclarithromycin Mediterranean spotted feverbusiness.industryChloramphenicolmedicine.diseaseSpotted feverSurgeryAnti-Bacterial AgentsBoutonneuse feverInfectious DiseasesRickettsiosisChloramphenicolChild PreschoolFemalebusinessmedicine.drug
researchProduct

A severe case of Israeli spotted fever with pleural effusion in Italy

2021

Abstract Background The most common Italian rickettsiosis is Mediterranean Spotted Fever (MSF). MSF is commonly associated with a symptom triad consisting of fever, cutaneous rash, and inoculation eschar. The rash is usually maculopapular but, especially in severe presentations, may be petechial. Other typical findings are arthromyalgia and headache. Herein, we describe for the first time an unusual case of Israeli spotted fever (ISF) associated with interstitial pneumonia and pleural effusion in which R. conorii subsp. israelensis was identified by molecular methods in the blood, as well as in the pleural fluid. Case presentation A 72-year-old male presented with a 10-day history of remitt…

Microbiology (medical)Malemedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaItaly Mediterranean spotted fever Pleural effusion Rickettsia Rickettsiales RickettsiosisSettore MED/17 - Malattie InfettivePleural effusionmedicine.medical_treatmentRickettsialesThoracentesisCase ReportEscharRickettsiosisBoutonneuse FeverMedicineHumansRickettsiaAgedbusiness.industryMediterranean spotted feverRickettsia InfectionsGeneral MedicinePetechial rashSpotted Fever Group Rickettsiosismedicine.diseaseRashDermatologyPleural effusionSpotted feverPneumoniaInfectious DiseasesRickettsiosisItalymedicine.symptombusinessInfection
researchProduct

First case of Mediterranean spotted fever-associated rhabdomyolysis leading to fatal acute renal failure and encephalitis

2014

SummaryMediterranean spotted fever (MSF) is a tick-borne zoonosis caused by Rickettsia conorii. In Italy, about 400 cases are reported every year and nearly half of them occur in Sicily, which is one of the most endemic regions. Although MSF is mostly a self-limited disease characterized by fever, skin rash, and a dark eschar at the site of the tick bite called a ‘tache noire’, serious complications are described, mainly in adult patients. Nevertheless, severe forms of the disease with major morbidity and a higher mortality risk have been described. We report a fatal case of MSF complicated by rhabdomyolysis, acute renal failure, and encephalitis in an elderly woman.

Microbiology (medical)medicine.medical_specialtyAcute renal failure; Encephalitis; Mediterranean spotted fever; Rhabdomyolysis; Rickettsia conoriiSettore MED/17 - Malattie InfettiveEscharTickBoutonneuse FeverRhabdomyolysislcsh:Infectious and parasitic diseasesAcute renal failureEncephalitimedicineHumanslcsh:RC109-216Agedbiologybusiness.industryZoonosisMediterranean spotted feverGeneral MedicineAcute Kidney Injurymedicine.diseasebiology.organism_classificationRashDermatologyVirologyRhabdomyolysiSpotted feverRickettsia conoriiInfectious DiseasesEncephalitisFemalemedicine.symptombusinessRickettsia conoriiRhabdomyolysisEncephalitisInternational Journal of Infectious Diseases
researchProduct